Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianfeng Pei

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Frontiers in Pharmacology|July 4, 2017
Innovating Chinese Herbal Medicine: From Traditional Health Practice to Scientific Drug DiscoveryShuo Gu, Jianfeng Pei
Evidence-Based Complementary and Alternative Medicine : Ecam|July 11, 2017
Chinese Herbal Medicine Meets Biological Networks of Complex Diseases: A Computational PerspectiveShuo Gu, Jianfeng Pei
Journal of Chemical Information and Modeling|May 17, 2017
Statistical Analysis and Prediction of Covalent Ligand Targeted Cysteine ResiduesWeilin Zhang, Jianfeng Pei, Luhua Lai
Current Pharmaceutical Design|October 23, 2012
Binding site detection and druggability prediction of protein targets for structure-based drug designYaxia Yuan, Jianfeng Pei, Luhua Lai
Journal of Molecular Modeling|October 14, 2009
A fast protein-ligand docking algorithm based on hydrogen bond matching and surface shape complementarityWenjia Luo, Jianfeng Pei, Yushan Zhu
Journal of Chemical Information and Computer Sciences|January 28, 2003
3D-QSAR and receptor modeling of tyrosine kinase inhibitors with flexible atom receptor model (FLARM)Tao Peng, Jianfeng Pei, Jiaju Zhou
Journal of Chemical Information and Modeling|April 26, 2011
LigBuilder 2: a practical de novo drug design approachYaxia Yuan, Jianfeng Pei, Luhua Lai
Communications Biology|January 12, 2020
A combined computational and experimental strategy identifies mutations conferring resistance to drugs targeting the BCR-ABL fusion proteinJinxin Liu, Jianfeng Pei, Luhua Lai
Chemical Science|November 11, 2021
Structure-based <i>de novo</i> drug design using 3D deep generative modelsYibo Li, Jianfeng Pei, Luhua Lai
Frontiers in Chemistry|March 18, 2020
LigBuilder V3: A Multi-Target <i>de novo</i> Drug Design ApproachYaxia Yuan, Jianfeng Pei, Luhua Lai
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Frontiers in Pharmacology|July 4, 2017
Innovating Chinese Herbal Medicine: From Traditional Health Practice to Scientific Drug DiscoveryShuo Gu, Jianfeng Pei
Evidence-Based Complementary and Alternative Medicine : Ecam|July 11, 2017
Chinese Herbal Medicine Meets Biological Networks of Complex Diseases: A Computational PerspectiveShuo Gu, Jianfeng Pei
Journal of Chemical Information and Modeling|May 17, 2017
Statistical Analysis and Prediction of Covalent Ligand Targeted Cysteine ResiduesWeilin Zhang, Jianfeng Pei, Luhua Lai
Current Pharmaceutical Design|October 23, 2012
Binding site detection and druggability prediction of protein targets for structure-based drug designYaxia Yuan, Jianfeng Pei, Luhua Lai
Journal of Molecular Modeling|October 14, 2009
A fast protein-ligand docking algorithm based on hydrogen bond matching and surface shape complementarityWenjia Luo, Jianfeng Pei, Yushan Zhu
Journal of Chemical Information and Computer Sciences|January 28, 2003
3D-QSAR and receptor modeling of tyrosine kinase inhibitors with flexible atom receptor model (FLARM)Tao Peng, Jianfeng Pei, Jiaju Zhou
Journal of Chemical Information and Modeling|April 26, 2011
LigBuilder 2: a practical de novo drug design approachYaxia Yuan, Jianfeng Pei, Luhua Lai
Communications Biology|January 12, 2020
A combined computational and experimental strategy identifies mutations conferring resistance to drugs targeting the BCR-ABL fusion proteinJinxin Liu, Jianfeng Pei, Luhua Lai
Chemical Science|November 11, 2021
Structure-based <i>de novo</i> drug design using 3D deep generative modelsYibo Li, Jianfeng Pei, Luhua Lai
Frontiers in Chemistry|March 18, 2020
LigBuilder V3: A Multi-Target <i>de novo</i> Drug Design ApproachYaxia Yuan, Jianfeng Pei, Luhua Lai
Pageof 9